FENNEC PHARMACEUTICALS INC. - Common stock, no par value (the "Shares") (FENC)

CUSIP: 31447P100

Q2 2018 13F Holders as of 30 Jun 2018

Type / Class
Equity / Common stock, no par value (the "Shares")
Shares outstanding
34,145,841
Total 13F shares
9,392,799
Share change
+1,768,938
Total reported value
$98,080,873
Price per share
$10.44
Number of holders
43
Value change
+$18,177,598
Number of buys
33
Number of sells
6

Quarterly Holders Quick Answers

What is CUSIP 31447P100?
CUSIP 31447P100 identifies FENC - FENNEC PHARMACEUTICALS INC. - Common stock, no par value (the "Shares") in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of FENNEC PHARMACEUTICALS INC. - Common stock, no par value (the "Shares") (FENC) as of Q2 2018

As of 30 Jun 2018, FENNEC PHARMACEUTICALS INC. - Common stock, no par value (the "Shares") (FENC) was held by 43 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 9,392,799 shares. The largest 10 holders included Southpoint Capital Advisors LP, venBio Select Advisor LLC, Opaleye Management Inc., 683 Capital Management, LLC, EVENTIDE ASSET MANAGEMENT, LLC, BlackRock Inc., PUTNAM INVESTMENTS LLC, ACUTA CAPITAL PARTNERS, LLC, STATE STREET CORP, and NORTHERN TRUST CORP. This page lists 43 institutional shareholders reporting positions in this security for the Q2 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.